The stalled RNA polymerase provides the key recognition signal for TCR. Rather than detecting damage uniformly across the genome, the pathway responds when a lesion interrupts RNA synthesis on the actively transcribed strand. Specialized factors then act at that blocked transcription complex, creating a route for repair to be directed to DNA whose damage is immediately threatening gene expression.
TCR and global-genome repair differ mainly in how damaged DNA is prioritized. TCR focuses on lesions encountered by RNA polymerase during transcription, whereas global-genome repair addresses damage more broadly. This division lets cells protect transcriptionally active regions while still addressing lesions elsewhere, so the pathways complement rather than duplicate one another.
After recognition, TCR factors can promote either repositioning or removal of the stalled polymerase. That step exposes or makes the lesion accessible to nucleotide excision repair machinery. The repair system then excises the damaged DNA, synthesizes a replacement strand, and supports renewed transcription. Thus, polymerase handling links damage recognition to physical restoration of the template.
Not every DNA lesion has the same immediate consequence for transcription. A transcription-blocking lesion halts RNA polymerase, making it a trigger for TCR and creating a direct risk to RNA production. Ultraviolet or chemical damage can generate such obstacles. Studying these lesions connects the nature of genotoxic damage with pathway activation and protection of gene expression.
A conceptual TCR workflow begins with a stalled RNA polymerase, followed by recognition of the blocked complex by specialized factors. The polymerase is repositioned or removed, nucleotide excision repair excises the damaged segment, and DNA synthesis replaces it. Completion of these steps restores the repaired template and allows transcription to resume, providing a functional outcome rather than lesion removal alone.
Researchers examine TCR to understand how cells prioritize genome maintenance during genotoxic stress. Experiments involving ultraviolet or chemical damage can reveal whether lesions block transcription, how stalled polymerase complexes are processed, and whether repair restores RNA synthesis. These outcomes help relate DNA damage to mutation avoidance and explain why defects in transcription-focused repair compromise cellular protection.
Transcription-coupled repair has particular medical relevance because defects in the pathway can cause Cockayne syndrome. This connection shows that repair is not only a molecular cleanup process: failure to protect transcription from blocking lesions can produce organism-level consequences. In biology, the pathway therefore links genome maintenance, gene expression, and disease.